Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Lymphoma, B-Cell Refractory”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT01328626
What this trial is testing

Study Evaluating the Safety and Pharmacokinetics of ABT-199 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia and Non-Hodgkin Lymphoma

Who this might be right for
Chronic Lymphocytic LeukemiaNon-Hodgkin Lymphoma
AbbVie 222
Early research (Phase 1)Study completedNCT00889408
What this trial is testing

DT2219ARL for Relapsed or Refractory CD19 (+), CD 22 (+) B-Lineage Leukemia Or Lymphoma

Who this might be right for
LeukemiaLymphoma
Masonic Cancer Center, University of Minnesota 25
Testing effectiveness (Phase 2)Study completedNCT00612716
What this trial is testing

Donor Stem Cell Transplant in Treating Patients With Previously Treated Lymphoma, Multiple Myeloma, or Chronic Lymphocytic Leukemia

Who this might be right for
LeukemiaLymphomaMultiple Myeloma and Plasma Cell Neoplasm
Masonic Cancer Center, University of Minnesota 6
Early research (Phase 1)Looking for participantsNCT07044050
What this trial is testing

A First-in-human Study to Assess OT-C001 (Amplified/Activated Allogenic Natural Killer Cells) in Patients With Relapsed/Refractory Diffuse Large B Cell Lymphoma

Who this might be right for
Diffuse Large B-cell Lymphoma With no Other Specification
Emercell SAS 10
Early research (Phase 1)Looking for participantsNCT06227026
What this trial is testing

Pilot Study of Anti-CD19 Chimeric Antigen Receptor T Cells (CAR-T Cells) for the Treatment of Relapsed/Refractory CD19+ Malignancies

Who this might be right for
Acute Lymphoblastic LeukemiaDiffuse Large B Cell Lymphoma
University of Utah 10
Testing effectiveness (Phase 2)Study completedNCT03664635
What this trial is testing

MB-CART20.1 Lymphoma

Who this might be right for
Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaB-cell Lymphoma Refractory+1 more
Miltenyi Biomedicine GmbH 10
Testing effectiveness (Phase 2)UnknownNCT03902197
What this trial is testing

CD19 hsCAR-T for Refractory/Relapsed CD19+ B-ALL Patients

Who this might be right for
Acute Lymphoblastic Leukemia
Xuanwu Hospital, Beijing 50
Testing effectiveness (Phase 2)UnknownNCT01240525
What this trial is testing

Donor Lymphocyte Infusion After Stem Cell Transplant in Treating Patients With Haematological Cancers

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
University College, London 114
Not applicableEnded earlyNCT00608517
What this trial is testing

Treatment of Single or Double Umbilical Cord Trans + Graft-versus-host Disease (GVHD) Prophylaxis w/ Tacrolimus & Mycophenolate Mofetil

Who this might be right for
Graft Versus Host DiseaseLeukemiaLymphoma+2 more
Vanderbilt-Ingram Cancer Center 6
Testing effectiveness (Phase 2)Ended earlyNCT05272813
What this trial is testing

Investigate the Efficacy and Safety of MS-553 in CLL/SLL

Who this might be right for
Lymphocytic LeukemiaSmall Lymphocytic Lymphoma
Shenzhen MingSight Relin Pharmaceuticals Co., Ltd. 13
Large-scale testing (Phase 3)Study completedNCT01197560
What this trial is testing

Study of Lenalidomide to Evaluate Safety and Effectiveness in Patients With Diffuse Large B-Cell Lymphoma (DLBCL)

Who this might be right for
Diffuse Large B-cell Lymphoma
Celgene 111
Early research (Phase 1)Study completedNCT00006368
What this trial is testing

Yttrium Y 90 SMT 487 in Treating Patients With Refractory or Recurrent Cancer

Who this might be right for
Brain and Central Nervous System TumorsBreast CancerGastrointestinal Carcinoid Tumor+5 more
Novartis Pharmaceuticals 60
Early research (Phase 1)Looking for participantsNCT05963217
What this trial is testing

Study of TBI-2001(Autologous CD19 Specific Chimeric Antigen Receptor (CAR) Gene-transduced T Lymphocytes) for Relapsed or Refractory CD19+ B-cell Lymphoma, CLL/SLL

Who this might be right for
Relapsed or Refractory CD19+ B-cell LymphomaRelapsed or Refractory Chronic Lymphocytic LeukemiaRelapsed or Refractory Small Lymphocytic Lymphoma
University Health Network, Toronto 19
Not applicableLooking for participantsNCT06678282
What this trial is testing

JY231(JY231) Injection for the Treatment of Relapsed or Refractory B Cell Lymphoma/ Leukemia

Who this might be right for
B-NHLB-ALL
Shenzhen Genocury Biotech Co., Ltd. 20
Early research (Phase 1)Ended earlyNCT03547115
What this trial is testing

Voruciclib Alone or in Combination With Venetoclax in Subjects With B-Cell Malignancies or AML

Who this might be right for
Follicular Lymphoma (FL)Mantle Cell Lymphoma (MCL)Marginal Zone Lymphoma (MZL)+4 more
MEI Pharma, Inc. 84
Testing effectiveness (Phase 2)UnknownNCT02134262
What this trial is testing

Gene Therapy for B-Cell Non-Hodgkin Lymphoma Using CD19 CAR Gene Transduced T Lymphocytes

Who this might be right for
Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma
Jichi Medical University 18
Testing effectiveness (Phase 2)Study completedNCT03770416
What this trial is testing

Nivolumab and Ibrutinib in Treating Patients With Relapsed or Refractory Central Nervous System Lymphoma

Who this might be right for
Central Nervous System B-Cell Non-Hodgkin LymphomaRecurrent Central Nervous System LymphomaRefractory Central Nervous System Lymphoma
M.D. Anderson Cancer Center 18
Testing effectiveness (Phase 2)Study completedNCT00831597
What this trial is testing

Bendamustine Combined With Rituximab for Patients With Relapsed or Refractory Diffuse Large B-Cell Lymphoma

Who this might be right for
Diffuse Large B-Cell Lymphoma
Pharmatech 61
Early research (Phase 1)Looking for participantsNCT06792734
What this trial is testing

Phase 1 Trial of BTM-3566 in Relapsed/Refractory Mature B Cell Lymphomas

Who this might be right for
Lymphoma, B-Cell
Bantam Pharmaceuticals 24
Very early researchUnknownNCT06277011
What this trial is testing

Safety and Efficacy of Metabolically Armed CD19 CAR-T Cells (Meta10-19) in the Treatment of Relapsed and/or Refractory CD19-positive B Cell Hematological Malignancies Clinical Research

Who this might be right for
Acute Lymphoblastic LeukemiaNon-hodgkin Lymphoma
Anhui Provincial Hospital 18
Next Page